Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
28 January 2011

IN THIS ISSUE
FDA validation guidance
Multaq safety review
Amgen and sanofi divest
Novartis acquisition

 
FDA publishes revised process-validation guidance
FDA published its long-awaited guidance titled Process Validation: General Principles and Practices this week. More...
 
Sanofi’s Multaq under safety review
The European Medicines Agency (EMA) has initiated a safety review of Sanofi’s anti-arrhythmic medicine Multaq following reports of serious liver injury in patients. More...
 
Amgen, sanofi-aventis divest manufacturing assets
Reflecting the manufacturing restructuring ongoing in the bio/pharmaceutical industry, Amgen and sanofi-aventis announced the sale of manufacturing facilities to contract manufacturers. More...
 
Novartis to acquire Genoptix
Novartis is looking to advance its personalized medicine treatment programs by entering into a definitive agreement to acquire Genoptix, a laboratory offering personalized diagnostic services, for approximately $470 million or $25 per share. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Magnetic pills a sign of the future?
Will the vise tighten on pay-for-delay agreements?
India rising
More blog posts

Latest articles
Printable medicines: a microdosing device for producing personalized medicines
The role of sterile filtration in the biopharm industry
Will DTC advertising appear in Europe?
More articles

Upcoming events
Tracking & Tracing of Prescription Drugs FDA Workshop (15–16 February | USA)
Pharmapack (23–24 February | France)
Pharma World Expo 2011 (23–26 February | UK)
More events

Product Profiles
Oxoid

Genetic Identification and Characterization in less than 8 Hours
The DuPont Qualicon RiboPrinter® microbial characterization system provides the speed, accuracy and resolution needed to identify bacteria and compare them at the strain level characterization, all in less than 8 hours. This automated system is available in Europe, Canada and Australia alongside Oxoid products. Read more...

 
Veltek

Veltek debuts new sterile clean room wipes, including the industry’s first sodium hypochlorite and hydrogen peroxide clean room wipes.
Veltek Associates, Inc., recently debuted four new sterile clean room wipes, including the HYPO-CHLOR® Saturated Sodium Hypochlorite Wipe and the STERI-PEROX®. Saturated Hydrogen Peroxide Wipe.
Read more...


Event Profile
 
placeholder

Pharma Test Expo
8-10 February 2011

Cologne, Germany

Test professionals can hear the latest on the subject at Pharma Test Expo 2011, to be held next February 8-10, in Cologne, Germany. Read more...

 

 



Survey
Which granulation technique is most commonly used in your company?
Wet granulation 76%
 
Dry granulation 24%

This week we would like to know...

FDA recently was granted the authority to issue recalls for food products. Should the agency have this power for pharmaceuticals as well?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom